Variant report
Variant | nsv980040 |
---|---|
Chromosome Location | chr3:144049507-144054115 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs552274935 | chr3:144051642-144051643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182896111 | chr3:144051650-144051651 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs186727119 | chr3:144051716-144051717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs549744306 | chr3:144051724-144051725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs553667362 | chr3:144051725-144051726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs197826 | chr3:144051770-144051771 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs539698253 | chr3:144051778-144051779 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148577204 | chr3:144051791-144051792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs142967697 | chr3:144051822-144051823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76708550 | chr3:144051826-144051827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs12634939 | chr3:144051833-144051834 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs552956499 | chr3:144051904-144051905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs577256908 | chr3:144051966-144051967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs116642075 | chr3:144051993-144051994 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114036054 | chr3:144052015-144052016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs574920674 | chr3:144052048-144052049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140090068 | chr3:144052126-144052127 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs560790718 | chr3:144052145-144052146 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527842329 | chr3:144052151-144052152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576375718 | chr3:144052171-144052172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs149915260 | chr3:144052193-144052194 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs557928104 | chr3:144052403-144052404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs576185499 | chr3:144052421-144052422 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538321526 | chr3:144052507-144052508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs556397372 | chr3:144052526-144052527 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs197827 | chr3:144052546-144052547 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs574305113 | chr3:144052612-144052613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373291401 | chr3:144052618-144052619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182904081 | chr3:144052639-144052640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs572768861 | chr3:144052675-144052676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546227945 | chr3:144052679-144052680 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs375602004 | chr3:144052687-144052688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs531824780 | chr3:144052713-144052714 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs570344926 | chr3:144052780-144052781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs549817957 | chr3:144052786-144052787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561448500 | chr3:144052800-144052801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188319282 | chr3:144052808-144052809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs115708958 | chr3:144052833-144052834 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs139675701 | chr3:144052838-144052839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533233486 | chr3:144052855-144052856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs531957034 | chr3:144052863-144052864 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs559968994 | chr3:144052949-144052950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs533481619 | chr3:144052983-144052984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs72999962 | chr3:144053030-144053031 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs57176920 | chr3:144053112-144053113 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191159136 | chr3:144053174-144053175 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs182205171 | chr3:144053235-144053236 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs556648711 | chr3:144053237-144053238 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs141013014 | chr3:144053247-144053248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144744943 | chr3:144053340-144053341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Cervical cancer | 21062161 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
microdeletion syndrome | 22180640 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Colorectal cancer | 18645599 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Blepharophimosis-ptosis-epicanthus inversus syndrome | 22067867 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 21129771 | CNVD |
Ovarian cancer | 23621864 | CNVD |
Breast cancer | 21364760 | CNVD |
Mental retardation | 17847001 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Breast cancer | 21509527 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20605837 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:144051600-144052200 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr3:144051600-144052200 | Enhancers | Primary B cells from peripheral blood | blood |
3 | chr3:144052400-144052600 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr3:144052600-144053600 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
5 | chr3:144053600-144054000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr3:144054000-144055200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |